SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001157523-13-003161
Filing Date
2013-06-26
Accepted
2013-06-26 06:46:49
Documents
15
Period of Report
2013-06-26
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 SUCAMPO PHARMACEUTICALS, INC. 8-K a50659810.htm 8-K 17005
2 EXHIBIT 99.1 a50659810ex99_1.htm EX-99.1 19842
3 SLIDE 1 slide1.jpg GRAPHIC 341292
4 SLIDE 2 slide2.jpg GRAPHIC 312009
5 SLIDE 3 slide3.jpg GRAPHIC 204711
6 SLIDE 4 slide4.jpg GRAPHIC 282751
7 SLIDE 5 slide5.jpg GRAPHIC 354610
8 SLIDE 6 slide6.jpg GRAPHIC 354175
9 SLIDE 7 slide7.jpg GRAPHIC 266947
10 SLIDE 8 slide8.jpg GRAPHIC 353144
11 SLIDE 9 slide9.jpg GRAPHIC 281074
12 SLIDE 10 slide10.jpg GRAPHIC 304224
13 SLIDE 11 slide11.jpg GRAPHIC 316739
14 SLIDE 12 slide12.jpg GRAPHIC 353405
15 SLIDE 13 slide13.jpg GRAPHIC 238595
  Complete submission text file 0001157523-13-003161.txt   5500763
Mailing Address 4520 EAST-WEST HIGHWAY, 3RD FLOOR BETHESDA MD 20814
Business Address 4520 EAST-WEST HIGHWAY, 3RD FLOOR BETHESDA MD 20814 3019613400
Sucampo Pharmaceuticals, Inc. (Filer) CIK: 0001365216 (see all company filings)

IRS No.: 133929237 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33609 | Film No.: 13933262
SIC: 2834 Pharmaceutical Preparations